Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06234878 · ClinicalTrials.gov registry record · NA
REEV SENSE for Gait Analysis in Post-stroke Gait Impairment (SENS-AG)
A NA study of Stroke and Gait Disorders, Neurologic, sponsored by REEV.
- Completed
- Registry status
- NA
- Development phase
- 23
- Enrollment target
- 1
- Study location
NCT06234878 is a NA study of Stroke and Gait Disorders, Neurologic that has completed, run by REEV. The registered enrollment target is 23 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06234878, a NA study of Stroke and Gait Disorders, Neurologic, has completed, sponsored by REEV.
- COMPLETED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the clinical performance of the investigational REEV SENSE gait tracker to measure gait features in subjects with post-stroke gait impairment. REEV SENSE is intended to be used by trained healthcare professionals as a simple procedure adapted to clinical routine. The reference method for performance comparison will be motion capture.
Conditions Studied
Interventions
- DEVICE REEV SENSE
- DEVICE Motion capture system
Study Locations (1)
Massachusetts
- MIT Center for Clinical and Translational Research - Cambridge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2024-01-08 |
| Est. Completion | 2025-04-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06234878
The ClinicalTrials.gov registry entry for NCT06234878 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The listed sponsor is REEV, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Stroke appearing as the primary indexed condition, and to 2 interventions - of which REEV SENSE is the first listed.
NCT06234878 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06234878 about?
NCT06234878 is a clinical study titled "REEV SENSE for Gait Analysis in Post-stroke Gait Impairment (SENS-AG)". The purpose of this study is to evaluate the clinical performance of the investigational REEV SENSE gait tracker to measure gait features in subjects with post-stroke gait impairment. REEV SENSE is intended to be used by trained healthcare professionals as a simple procedure adapted to clinical rou...
What is the current status of trial NCT06234878?
This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2024-01-08. Estimated completion is 2025-04-01.
What conditions does trial NCT06234878 study?
This clinical trial studies the following conditions: Stroke, Gait Disorders, Neurologic.
What interventions are being tested in trial NCT06234878?
The interventions under investigation include: REEV SENSE (DEVICE), Motion capture system (DEVICE).
Who is sponsoring clinical trial NCT06234878?
This trial is sponsored by REEV, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06234878 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Tracking a Tactile Signal Along the Nervous System
RECRUITING · NA
-
Transcranial Direct Current Stimulation (tDCS) With Verb Network Strengthening Treatment (VNeST) in Chronic Aphasia
RECRUITING · NA
-
Strategy Training for Individuals With Unilateral Neglect
RECRUITING · NA
-
Weight Loss and ExeRcise
RECRUITING · NA
-
Safety and Feasibility of an ExoNET for Supination Assistance for Stroke Survivors
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.